OCTAPLASLG

This brand name is authorized in Croatia, Ecuador, Estonia, Finland, France, Malta, Poland, Romania, UK.

Active ingredients

The drug OCTAPLASLG contains one active pharmaceutical ingredient (API):

1	UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)
	Read more about

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OCTAPLASLG Solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05AA	Blood substitutes and plasma protein fractions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products
Discover more medicines within B05AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	223-MBE-1221
EE	Ravimiamet	1593187, 1674592, 1674604, 1685235, 1802652, 1802663, 1802674, 1802685
FI	Lääkealan turvallisuus- ja kehittämiskeskus	004263, 004280, 004295, 004297
FR	Base de données publique des médicaments	60074795
GB	Medicines & Healthcare Products Regulatory Agency	336602, 336605, 336610, 336613
HR	Agencija za lijekove i medicinske proizvode	HR-H-098600779, HR-H-223252057
MT	Medicines Authority	MA1219/00901, MA1219/00902
PL	Rejestru Produktów Leczniczych	100340046
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65357001, W65357002, W65357003, W65357004